TEWKSBURY, Mass., Sept. 2, 2020 /PRNewswire/ -- Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotopes and stable isotope-labeled compounds, recently announced a capacity expansion for deuterated benzene at Cambridge Isotope Separations, LLC (CIS), located on 33 acres in Xenia, Ohio. This capacity expansion started in the summer of 2019 and consisted of two new reactors being added; the first was active in January 2020 and the second new reactor came online this summer. To complete the final phase of this expansion, an additional distillation unit will be active by the end of 2020. This is the first deuterated benzene capacity expansion at CIS since the process began in 2008.
Cambridge Isotope Laboratories, Inc. (CIL) has announced that the company is working together with IROA Technologies LLC (IROATECH), a leading developer of novel analytical tools for accurate metabolic analysis, to help develop and distribute IROA Biochemical Quantitation Kits worldwide for metabolic profiling of various cell populations and biological samples.